Month: May 2024

PALM BEACH GARDENS, Fla., May 10, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2025 first quarter results on Wednesday, May 22, 2024, at 9:00 a.m. Eastern time. Dycom will issue a press release reporting its results earlier that morning. Interested parties may participate in the question and answer session of the conference call by registering at https://register.vevent.com/register/BI1c2e72a7bcd9487582598a90de01968e. Upon registration, participants will receive a dial-in number and unique PIN to access the call. Participants are encouraged to join approximately ten minutes prior to the scheduled start time. For all other attendees, a live listen-only audio webcast of the call, including an accompanying slide presentation, can be accessed directly at https://edge.media-server.com/mmc/p/pyhc9s3t....

— Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial data from planned Phase 1/2 clinical trial expected in 2025 — — Presented new preclinical data demonstrating broad potential of Prime Editing technology at LNP Formulation and Process Development Summit and ASGCT 2024 — — Appointed Tony Coles, M.D. as senior advisor — CAMBRIDGE, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results for the first quarter ended March 31, 2024, and provided a business update. “In 2024, we expect to bring the first-ever Prime Editing-based product candidate to patients, while...

Strong Revenue Growth, Refinancing Underway, 2024 Outlook Reaffirmed LOUISVILLE, Ky., May 10, 2024 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced its financial results for the fiscal first quarter ended March 31, 2024. Highlights:Record first quarter revenue of $12.3 million, up 24% from $9.9 million in the prior-year period Gross profit of $5.8 million for the three months ended March 31, 2024 versus $5.1 million in the first quarter of fiscal 2023 Adjusted EBITDA* of $0.8 million for the first quarter of 2024 versus $1.0 million in the prior-year period Annual recurring revenue (“ARR”) of approximately $17.7 million at the end of the first quarter versus $16.3 million at the beginning of the fiscal...

FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced financial results for the first quarter ended March 31, 2024, and provided a corporate update. “Ocuphire has made significant progress in 2024, with important developments for both APX3330 and RYZUMVI™,” said George Magrath, M.D., M.B.A., M.S., CEO of Ocuphire. “We have been engaged in productive dialogue with the U.S. Food and Drug Administration (FDA) with respect to our submitted Special Protocol Assessment (SPA) to formalize the protocol and statistical analysis plan for future Phase 2/3 registrational trials of APX3330 in diabetic retinopathy...

AEHL Records 78% Revenue Growth in 2nd Year of Operating its Livestreaming Ecommerce Business NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a livestreaming ecommerce business in China with access to 800,000+ hosts and influencers, today announced its financial results for the second half and fiscal year ended December 31, 2023. Fiscal Year 2023 SummaryRevenue was RMB 510.5 million (US$ 72.1 million), a 78.3% increase as compared to RMB 286.3 million (US$ 42.6 million) for fiscal year 2022. Gross profit was RMB 53.1 million (US$ 7.5 million), 90.0% increase as compared to RMB 27.9 million (US$ 4.1 million) for fiscal 2022. Net loss was RMB 14.5 million (US$ 2.0 million), as compared to a net...

All amounts in U.S. dollars unless otherwise stated TORONTO, May 10, 2024 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) today announced its financial results for the first quarter ended March 31, 2024. “Onex is making progress in its plans to drive growth in shareholder value, and we were pleased to see fundraising start to gain momentum in the quarter,” said Bobby Le Blanc, Chief Executive Officer. “We continue to focus our capital deployment and resource allocation on areas where we have a proven track record and the right to compete.” Financial Results(unaudited, $ millions except per share amounts) Three Months Ended March 31    2024   2023  Net earnings (loss) $ 10   $ (232 )Net earnings (loss) per diluted share $ 0.13   $ (2.87 )         Investing segment net earnings $ 54   $ 44  Asset management segment...